Renal cell carcinoma (RCC) is the most common type of kidney cancer, and accounts for over 90 percent of all renal malignancies. This presentation encompasses a discussion relative to the recognition and management of renal cell carcinoma.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/16/2027.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
There are no disclosures to declare.

Speaker Disclosures:
There are no speaker disclosures to declare.

Commercial Support:
No commercial support declared.

Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the participant will report an improved ability to recognize and manage RCC.

Yousra Elsir PA-C, MSPA, DMS

Appearances